ACACIA RESEARCH CORP ACTG
Nasdaq · XNAS · stock · Patent Owners & Lessors
Chart by TradingView
8/9
Piotroski F — financial health
5.67
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $285.2M | $21.7M | $84.5M | — | $584.0M |
| 2024 | $122.3M | -$36.1M | $29.7M | -$98.5M | $552.6M |
| 2023 | $125.1M | $67.1M | $72.3M | -$22.7M | $589.6M |
| 2022 | $59.2M | -$125.1M | $21.8M | -$38.1M | $269.3M |
| 2021 | $88.0M | $149.2M | $51.9M | $13.2M | $430.5M |
| 2020 | $29.8M | $109.2M | — | -$19.8M | $288.3M |
Why these scores methodology →
Piotroski F-score: 8/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.67 (safe)
- Working capital / assets 0.52
- Retained earnings / assets -0.33
- EBIT / assets 0.008
- Equity / liabilities 3.124
Source: SEC EDGAR filings · CIK 0000934549 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.